Literature DB >> 10882678

Serological detection of infection with diverse human and simian immunodeficiency viruses using consensus env peptides.

S Masciotra1, D L Rudolph, G van der Groen, C Yang, R B Lal.   

Abstract

Cross-species transmission has been shown to play an important role in the emergence of human retroviruses. We developed a generic enzyme immunoassay using synthetic peptides from gp41 and C2V3 consensus sequences (human immunodeficiency virus [HIV] type 1 [HIV-1] groups M, O, and N and the homologous region of simian immunodeficiency virus [SIV] strains from chimpanzees [SIVcpz], SIVcpzGAB1 and SIVcpzANT) to detect divergent HIV and SIV. A cocktail of peptides from gp41 and C2V3 (M-O) detected all HIV-1 group M and O sera and showed cross-reactivity with SIVcpz sera. Further, a mixture of C2V3 peptides (GAB1-ANT) failed to detect HIV-1 infections but reacted with all SIVcpz sera, allowing discrimination of SIVcpz from HIV-1 infections. Since most SIVcpz sera cross-reacted with HIV-1 peptides, we next evaluated SIVcpz serum reactivity with rapid tests for HIV-1/2. SIVcpzANT and SIVcpzUS sera reacted with the Sero-strip and Multispot assays. Both tests are sensitive in detecting group M (97 100%, respectively), although Multispot has lower sensitivity for group O detection (67%) than does Sero-strip (100%). The limited volume and time required to perform these assays make them a generic tool for field screening. The env peptide-based assay and rapid tests should allow for the identification of emerging variants of HIV and SIV.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882678      PMCID: PMC95940          DOI: 10.1128/CDLI.7.4.706-709.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  12 in total

1.  Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.

Authors:  J Dorn; S Masciotra; C Yang; R Downing; B Biryahwaho; T D Mastro; J Nkengasong; D Pieniazek; M A Rayfield; D J Hu; R B Lal
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Comparative evaluation of 36 commercial assays for detecting antibodies to HIV.

Authors:  I Van Kerckhoven; G Vercauteren; P Piot; G van der Groen
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

3.  Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs.

Authors:  C Yang; B C Dash; F Simon; G van der Groen; D Pieniazek; F Gao; B H Hahn; R B Lal
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

4.  More ado about HIV's origins.

Authors:  S Wain-Hobson
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

5.  From Pan to pandemic.

Authors:  R A Weiss; R W Wrangham
Journal:  Nature       Date:  1999-02-04       Impact factor: 49.962

6.  Cross-species transmission and recombination of 'AIDS' viruses.

Authors:  P M Sharp; D L Robertson; B H Hahn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1995-07-29       Impact factor: 6.237

7.  Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

Authors:  F Simon; P Mauclère; P Roques; I Loussert-Ajaka; M C Müller-Trutwin; S Saragosti; M C Georges-Courbot; F Barré-Sinoussi; F Brun-Vézinet
Journal:  Nat Med       Date:  1998-09       Impact factor: 53.440

8.  Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.

Authors:  M B Oldstone; A Tishon; H Lewicki; H J Dyson; V A Feher; N Assa-Munt; P E Wright
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

9.  Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers.

Authors:  C Yang; D Pieniazek; S M Owen; C Fridlund; J Nkengasong; T D Mastro; M A Rayfield; R Downing; B Biryawaho; A Tanuri; L Zekeng; G van der Groen; F Gao; R B Lal
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

10.  Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.

Authors:  F Gao; E Bailes; D L Robertson; Y Chen; C M Rodenburg; S F Michael; L B Cummins; L O Arthur; M Peeters; G M Shaw; P M Sharp; B H Hahn
Journal:  Nature       Date:  1999-02-04       Impact factor: 49.962

View more
  4 in total

1.  Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants.

Authors:  W H Koch; P S Sullivan; C Roberts; K Francis; R Downing; T D Mastro; J Nkengasong; D Hu; S Masciotra; C Schable; R B Lal
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Generation of a specific-pathogen-free baboon colony.

Authors:  Roman F Wolf; Richard Eberle; Gary L White
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

3.  New multiple antigenic peptide-based enzyme immunoassay for detection of simian immunodeficiency virus infection in nonhuman primates and humans.

Authors:  C B Ndongmo; W M Switzer; C P Pau; C Zeh; A Schaefer; D Pieniazek; T M Folks; M L Kalish
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Detection of simian immunodeficiency virus in diverse species and of human immunodeficiency virus Type 2 by using consensus primers within the pol region.

Authors:  Silvina Masciotra; Chunfu Yang; Danuta Pieniazek; Chanda Thomas; Sherry M Owen; Harold M McClure; Renu B Lal
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.